| 1 |
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Psychiatry, 2022, 9(2):137-150.
|
| 2 |
Sepúlveda-Lizcano L, Arenas-Villamizar VV, Jaimes-Duarte EB, et al. Metabolic adverse effects of psychotropic drug therapy:a systematic review[J]. Eur J Investig Health Psychol Educ, 2023, 13(8):1505-1520.
|
| 3 |
Leo DG, Islam U, Lotto RR, et al. Psychological interventions for depression in adolescent and adult congenital heart disease[J]. Cochrane Database Syst Rev, 2023, 10(10):Cd004372.
|
| 4 |
Villanueva R. Stem cell therapy for the treatment of psychiatric disorders:a real hope for the next decades[J]. Front Psychiatry, 2024, 15:1492415.
|
| 5 |
Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future[J]. Stem Cell Res Ther, 2019, 10(1):68.
|
| 6 |
Huang J, Huang W, Yi J, et al. Mesenchymal stromal cells alleviate depressive and anxiety-like behaviors via a lung vagal-to-brain axis in male mice[J]. Nat Commun, 2023, 14(1):7406.
|
| 7 |
Tang Y, Cui YC, Wang XJ, et al. Neural progenitor cells derived from adult bone marrow mesenchymal stem cells promote neuronal regeneration[J]. Life Sci, 2012, 91(19-20):951-958.
|
| 8 |
Silva AYO, Amorim éA, Barbosa-Silva MC, et al. Mesenchymal stromal cells protect the blood-brain barrier, reduce astrogliosis, and prevent cognitive and behavioral alterations in surviving septic mice[J]. Crit Care Med, 2020, 48(4):e290-e298.
|
| 9 |
Trujillo CA, Gao R, Negraes PD, et al. Complex oscillatory waves emerging from cortical organoids model early human brain network development[J]. Cell stem cell, 2019, 25(4):558-69.e7.
|
| 10 |
Portmann-Lanz CB, Schoeberlein A, Portmann R, et al. Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes[J]. Am J Obstet Gynecol, 2010, 202(3):294.e1-294.e11.
|
| 11 |
Asgari Taei A, Dargahi L, Khodabakhsh P, et al. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke[J]. CNS Neurosci Ther, 2022, 28(9):1425-1438.
|
| 12 |
Sultan N, Amin LE, Zaher AR, et al. Neurotrophic effects of dental pulp stem cells on trigeminal neuronal cells[J]. Sci Rep, 2020, 10(1):19694.
|
| 13 |
Liu S, Fan M, Xu JX, et al. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology[J]. J Neuroinflammation, 2022, 19(1):35.
|
| 14 |
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation:double trouble[J]. Neuron, 2020, 107(2):234-256.
|
| 15 |
Vázquez-González D, Carreón-Trujillo S, Alvarez-Arellano L, et al. A potential role for neuroinflammation in ADHD[J]. Adv Exp Med Biol, 2023, 1411:327-356.
|
| 16 |
宋浦蓁, 马贺宾, 陈宏广, 等. 骨髓间充质干细胞外泌体联合转化生长因子β1对巨噬细胞的作用[J/OL]. 中国组织工程研究, 2026, 30(7): 1616-1623. 2025年3月21日网络优先发表].
URL
|
| 17 |
赵仁礼. 骨髓间充质干细胞外泌体通过调节树突状细胞功能促进异体移植免疫耐受[D]. 广州:南方医科大学, 2021.
|
| 18 |
Lima MN, Oliveira HA, Fagundes PM, et al. Mesenchymal stromal cells protect against vascular damage and depression-like behavior in mice surviving cerebral malaria[J]. Stem Cell Res Ther, 2020, 11(1):367.
|
| 19 |
Wikarska A, Roszak K, Roszek K. Mesenchymal stem cells and purinergic signaling in autism spectrum disorder: bridging the gap between cell-based strategies and neuro-immune modulation[J]. Biomedicines, 2024, 12(6):1310.
|
| 20 |
You MJ, Bang M, Park HS, et al. Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation[J]. Transl Psychiatry, 2020, 10(1):123.
|
| 21 |
Lu B, Lin L, Su X. Global burden of depression or depressive symptoms in children and adolescents: a systematic review and meta-analysis[J]. J Affect Disord, 2024, 354:553-562.
|
| 22 |
Jauhar S, Johnstone M, Mckenna PJ. Schizophrenia[J]. Lancet, 2022, 399(10323):473-486.
|
| 23 |
Solmi M, Seitidis G, Mavridis D, et al. Incidence, prevalence, and global burden of schizophrenia-data, with critical appraisal, from the Global Burden of Disease(GBD) 2019[J]. Mol Psychiatry, 2023, 28(12):5319-5327.
|
| 24 |
Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China:a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3):211-224.
|
| 25 |
吴旻熹, 洪语欣, 黄夏仪, 等. 精神分裂症的病理机制及治疗方法进展[J]. 广东药科大学学报, 2024, 40(6):136-143.
|
| 26 |
Correll CU, Abi-Dargham A, Howes O. Emerging treatments in schizophrenia[J]. J Clin Psychiatry, 2022, 83(1):SU21024IP1.
|
| 27 |
Zhong XL, Huang Y, Du Y, et al. Unlocking the therapeutic potential of exosomes derived from nasal olfactory mucosal mesenchymal stem cells:restoring synaptic plasticity, neurogenesis, and neuroinflammation in schizophrenia[J]. Schizophr Bull, 2024, 50(3):600-614.
|
| 28 |
Dali P, Shende P. Advances in stem cell therapy for brain diseases via the intranasal route[J]. Curr Pharm Biotechnol, 2021, 22(11):1466-1481.
|
| 29 |
Chang Z, Wang QY, Li LH, et al. Potential plausible role of stem cell for treating depressive disorder: a retrospective review[J]. Mol Neurobiol, 2024, 61(7):4454-4472.
|
| 30 |
Cai H, Jin Y, Liu S, et al. Prevalence of suicidal ideation and planning in patients with major depressive disorder:a meta-analysis of observation studies[J]. J Affect Disord, 2021, 293:148-158.
|
| 31 |
Zhang H, Xie XH, Xu SX, et al. Oligodendrocyte-derived exosomes-containing SIRT2 ameliorates depressive-like behaviors and restores hippocampal neurogenesis and synaptic plasticity via the AKT/GSK-3β pathway in depressed mice[J]. CNS Neurosci Ther, 2024, 30(3):e14661.
|
| 32 |
沈钊舟. 人脱落乳牙牙髓干细胞治疗重度抑郁症的研究[D].长沙:中南大学, 2022.
|
| 33 |
陈晓辉, 王国强, 尚立芝, 等. 加味丹栀逍遥散联合脐带间充质干细胞治疗中风后抑郁症的临床观察[J]. 中国病理生理杂志, 2019, 35(12):2274-2279.
|
| 34 |
De Lima TA, Zuanetti PA, Nunes MEN, et al. Differential diagnosis between autism spectrum disorder and other developmental disorders with emphasis on the preschool period[J]. World J Pediatr, 2023, 19(8):715-726.
|
| 35 |
Fombonne E. Editorial:The rising prevalence of autism[J]. J Child Psychol Psychiatry, 2018, 59(7):717-720.
|
| 36 |
Hirota T, King H. Autism spectrum disorder: a review[J]. JAMA, 2023, 329(2):157-168.
|
| 37 |
张竞, 贾相斌, 夏昆, 等. 孤独症谱系障碍的遗传病因和神经生物学机制[J]. 中国科学:生命科学, 2024，54(11):2051-2067.
|
| 38 |
Havdahl A, Niarchou M, Starnawska A, et al. Genetic contributions to autism spectrum disorder[J]. Psychol Med, 2021, 51(13):2260-2273.
|
| 39 |
Arranz MJ, Salazar J, Bote V, et al. Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers[J]. Pharmaceutics, 2022, 14(5):999.
|
| 40 |
Tao R, Yang Y, Wilson M, et al. Comparative effectiveness of physical activity interventions on cognitive functions in children and adolescents with neurodevelopmental disorders: a systematic review and network meta-analysis of randomized controlled trials[J]. Int J Behav Nutr Phys Act, 2025, 22(1):6.
|
| 41 |
Carpenter KLH, Major S, Tallman C, et al. White matter tract changes associated with clinical improvement in an open-label trial assessing autologous umbilical cord blood for treatment of young children with autism[J]. Stem Cells Transl Med, 2019, 8(2):138-147.
|
| 42 |
Zhang R, Cai Y, Xiao R, et al. Human amniotic epithelial cell transplantation promotes neurogenesis and ameliorates social deficits in BTBR mice[J]. Stem Cell Res Ther, 2019, 10(1):153.
|
| 43 |
Qin Q, Shan Z, Xing L, et al. Synergistic effect of mesenchymal stem cell-derived extracellular vesicle and miR-137 alleviates autism-like behaviors by modulating the NF-κB pathway[J]. J Transl Med, 2024, 22(1):446.
|